VIRALEZE SPL7013 highly active in UK variant of coronavirus
Filed with ASX · · 5 pages · English
Starpharma Holdings Limited on 6ix
Earlier from Starpharma
- VIRALEZE launches in Europe
- VIRALEZE™ now launched by LloydsPharmacy in the UK
- VIRALEZE to be launched with LloydsPharmacy in the UK
- DEP HER2-lutetium outperforms in human breast cancer model
- VIRALEZE antiviral nasal spray registered in Europe
Later from Starpharma
- VIRALEZE antiviral nasal spray registered for sale in India
- VIRALEZE SPL7013 virucidal against multiple COVID variants
- VIRALEZE UK Update
- VIRALEZE SPL7013 virucidal against SARS-CoV-2 Delta variant
- VIRALEZE well tolerated in multiple dose clinical study
Follow Starpharma into a list and get an email when it puts out news.
Follow Starpharma